Claims
- 1-35. (Canceled)
- 36. A method of identifying a compound as a modulator of G-protein-linked receptor activity that generates or consumes a cyclic nucleotide through the action of a cyclase or phosphodiesterase, comprising:
conducting a G-protein-linked-receptor mediated reaction that generates or consumes a cyclic nucleotide in the presence of a candidate compound; contacting, in vitro, a product of the reaction with a luminescent tracer and with the opposite member of a specific binding pair to the cyclic nucleotide, wherein the tracer and the cyclic nucleotide compete for binding to the opposite member of the specific binding pair; illuminating the tracer with polarized light, wherein the light is capable of inducing emission of polarized light from the tracer; detecting the extent of polarization of light emitted from the tracer; and identifying the candidate compound as a modulator of the reaction based on the extent of polarization of the emitted light.
- 37. The method of claim 36, wherein the cyclic nucleotide is selected from the group consisting of cAMP and cGMP.
- 38. The method of claim 36, wherein the opposite member of a specific binding pair is an immunological binding partner.
- 39. The method of claim 36, wherein the extent of polarization is determined using a function selected from the group consisting of polarization and anisotropy.
- 40. The method of claim 36, wherein the extent of polarization of the emitted light is inversely correlated with the concentration of the cyclic nucleotide.
- 41. The method of claim 36, further comprising determining the concentration of the cyclic nucleotide.
- 42. The method of claim 36, wherein the reaction is conducted using whole cells.
- 43. The method of claim 36, wherein the reaction is conducted using lysed cells.
- 44. The method of claim 36, wherein the reaction generates a cyclic nucleotide.
- 45. The method of claim 44, wherein the reaction generates a cyclic nucleotide through the action of a cyclase.
- 46. The method of claim 36, wherein the reaction consumes a cyclic nucleotide.
- 47. The method of claim 46, wherein the reaction consumes a cyclic nucleotide through the action of a phosphodiesterase.
- 48. The method of claim 36, further comprising repeating the steps of conducting, contacting, illuminating, and detecting in the absence of a candidate compound, wherein the step of identifying the candidate compound as a modulator includes comparing the extent of polarization of the emitted light based on the reaction conducted in the presence of the candidate compound to the extent of polarization of the emitted light based on the reaction conducted in the absence of the candidate compound.
- 49. The method of claim 48, the reaction generating a cyclic nucleotide, wherein an increase in the extent of polarization when the reaction is conducted in the presence of the candidate compound in comparison with the extent of polarization when the reaction is conducted in the absence of the candidate compound identifies the candidate compound as an inhibitor of the reaction, and wherein a decrease in the extent of polarization when the reaction is conducted in the presence of the candidate compound in comparison with the extent of polarization when the reaction is conducted in the absence of the candidate compound identifies the candidate compound as an agonist of the reaction.
- 50. The method of claim 48, the reaction consuming a cyclic nucleotide, wherein an increase in the extent of polarization when the reaction is conducted in the presence of the candidate compound in comparison with the extent of polarization when the reaction is conducted in the absence of the candidate compound identifies the candidate compound as an agonist of the reaction, and wherein a decrease in the extent of polarization when the reaction is conducted in the presence of the candidate compound in comparison with the extent of polarization when the reaction is conducted in the absence of the candidate compound identifies the candidate compound as an inhibitor of the reaction.
- 51. The method of claim 36, the reaction generating a cyclic nucleotide, wherein the step of conducting the reaction includes providing a nucleotide triphosphate.
- 52. The method of claim 36, the reaction consuming a cyclic nucleotide, wherein the step of conducting the reaction includes providing the cyclic nucleotide.
- 53. The method of claim 36, further comprising repeating the steps of conducting, contacting, illuminating, detecting, and identifying for a different candidate compound.
- 54. The method of claim 53, at least one of the steps being performed using a microplate, wherein a different well of the microplate is used for each different candidate compound.
- 55. The method of claim 36, wherein at least one of the steps of conducting, contacting, illuminating, detecting, and identifying is performed using a microplate.
- 56. The method of claim 36, the step of conducting the reaction being performed in a reaction volume, wherein the step of contacting includes adding the luminescent tracer and the opposite member of a specific binding pair to the reaction volume.
- 57. The method of claim 36, wherein the luminescent tracer comprises a cyclic nucleotide coupled to a luminophore.
- 58. The method of claim 36, the step of conducting a reaction being performed inside a cell, further comprising the step of lysing the cell to obtain the product of the reaction prior to the steps of contacting, illuminating, detecting, and identifying.
- 59. The method of claim 36, wherein the G-protein-linked receptor generates cAMP through G-protein activation and adenylate cyclase activity.
- 60. The method of claim 36, wherein the candidate compound is a modulator of the G-protein-linked receptor.
CROSS-REFERENCES
[0001] This application is a continuation of PCT Patent Application Serial No. PCT/US00/16012, filed Jun. 9, 2000, which is incorporated herein by reference.
[0002] This application is based upon and claims priority under 35 U.S.C. § 119 from the following U.S. Provisional Patent Applications, each of which is incorporated herein by reference: Serial No. 60/138,311, filed Jun. 9, 1999; Serial No. 60/182,036, filed Feb. 11, 2000; and Serial No. 60/200,594, filed Apr. 28, 2000.
[0003] This application incorporates by reference the following U.S. patent applications: Ser. No. 08/840,553, filed Apr. 14, 1997; Ser. No. 08/929,095, filed Sep. 15, 1997; Ser. No. 09/118,141, filed Jul. 16, 1998; Ser. No. 09/144,575, filed Aug. 31, 1998; Ser. No. 09/144,578, filed Aug. 31, 1998; Ser. No. 09/146,081, filed Sep. 2, 1998; Ser. No. 09/156,318, filed Sep. 18, 1998; Ser. No. 09/160,533, filed Sep. 24, 1998; Ser. No. 09/302,158, filed Apr. 29, 1999; Ser. No. 09/349,733, filed Jul. 8, 1999; Ser. No. 09/468,440, filed Dec. 21, 1999; Ser. No. 09/478,819, filed Jan. 5, 2000; Ser. No. 09/494,407, filed Jan. 28, 2000; and Ser. No. 09/556,030, filed Apr. 20, 2000.
[0004] This application also incorporates by reference the following PCT patent applications: Serial No. PCT/US99/01656, filed Jan. 25, 1999; Serial No. PCT/US99/03678, filed Feb. 19, 1999; Serial No. PCT/US99/08410, filed Apr. 16, 1999; Serial No. PCT/US99/16057, filed Jul. 15, 1999; Serial No. PCT/US99/16453, filed Jul. 21, 1999; Serial No. PCT/US99/16621, filed Jul. 23, 1999; Serial No. PCT/US99/16286, filed Jul. 26, 1999; Serial No. PCT/US99/16287, filed Jul. 26, 1999; Serial No. PCT/US99/24707, filed Oct. 19, 1999; Serial No. PCT/US00/00895, filed Jan. 14, 2000; Serial No. PCT/US00/03589, filed Feb. 11, 2000; Serial No. PCT/US00/04543, filed Feb. 22, 2000; Serial No. PCT/US00/06841, filed Mar. 15, 2000; Serial No. PCT/US00/12277, filed May 3, 2000; Serial No. PCT/US00/16025, filed Jun. 9, 2000; and Serial No. PCT/US00/15774, filed Jun. 9, 2000.
[0005] This application also incorporates by reference the following U.S. provisional patent applications: Serial No. 60/138,438, filed Jun. 10, 1999; Serial No. 60/138,737, filed Jun. 11, 1999; Serial No. 60/138,893, filed Jun. 11, 1999; Serial No. 60/142,721, filed Jul. 7, 1999; Serial No. 60/143,185, filed Jul. 9, 1999; Serial No. 60/153,251, filed Sep. 10, 1999; Serial No. 60/164,633, filed Nov. 10, 1999; 60/165,813, filed Nov. 16, 1999; Serial No. 60/167,301, filed Nov. 24, 1999; Serial No. 60/167,463, filed Nov. 24, 1999; Serial No. 60/178,026, filed Jan. 26, 2000; Serial No. 60/182,419, filed Feb. 14, 2000; Serial No. 60/184,719, filed Feb. 24, 2000; Serial No. 60/184,924, filed Feb. 25, 2000; Serial No. 60/190,265, filed Mar. 17, 2000; Serial No. 60/191,890, filed Mar. 23, 2000; Serial No. 60/193,586, filed Mar. 30, 2000; Serial No. 60/197,324, filed Apr. 14, 2000; Serial No. 60/200,530, filed Apr. 27, 2000; and Serial No. 60/202,087, filed May 4, 2000.
Provisional Applications (3)
|
Number |
Date |
Country |
|
60138311 |
Jun 1999 |
US |
|
60182036 |
Feb 2000 |
US |
|
60200594 |
Apr 2000 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCT/US00/16012 |
Jun 2000 |
US |
Child |
09768661 |
Jan 2001 |
US |